about
Early life programming as a target for prevention of child and adolescent mental disordersPharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachAntipsychotic drugs in pregnancy: a review of their maternal and fetal effectsCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Hyperemesis gravidarum: current aspect.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Prenatal and neonatal brain structure and white matter maturation in children at high risk for schizophreniaObstetric and neonatal outcomes after antipsychotic medication exposure in pregnancyCortical thickness and surface area in neonates at high risk for schizophrenia.Decisions about the use of psychotropic medication during pregnancy: a qualitative studyAltered structural connectivity in neonates at genetic risk for schizophrenia: a combined study using morphological and white matter networks.Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care.Migraine therapy during pregnancy and lactation.The clinical management of hyperemesis gravidarum.Bipolar disorder differences between genders: special considerations for women.Treatment-emergent adverse events associated with atypical antipsychotics.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatioRevisiting loxapine: a systematic review.Antipsychotic use in pregnancy.Use of psychotropic drugs during pregnancy and breast-feeding.Multiple drug transporters mediate the placental transport of sulpiride.Depression During Pregnancy and Postpartum.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Treatment of psychosis during pregnancy - a case report and a mini-review.Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures.Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey.Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme
P2860
Q21245282-91119140-BCAD-4B5F-B148-1D8A89A0140EQ26774013-5ABF3894-F632-4DB2-846D-7435035A4297Q26824299-7D49354E-A408-414D-B8E4-6217365BCEDCQ27009995-402BA2AC-3940-483B-9AA9-6CBEC9821EAEQ30249670-6FF9B1F6-CB50-4EB2-AB21-6D71661D10C3Q34232791-93775473-143A-4FC5-883E-7B2F2E289E04Q34623350-0BAB2A9F-D4F7-4C0A-8F6F-A9C5665D808CQ34823805-39EA36E7-9352-4220-93A1-955483A871C6Q35016170-7AA0CF49-4544-4467-B1A0-10F797BB0872Q35017770-C02D6D57-0890-45B8-BF43-9E3FF15AEA7AQ35564275-31A9E887-8B8D-4953-8193-FF44BA9230DFQ35674895-1AEA2A6C-5AFF-48DD-B5B9-4BD3921AEEFDQ35906006-92C5DE20-E634-434F-9A44-A331DBAC8165Q36128409-94D06710-97C3-4F68-A61D-15FD0471D7B8Q37683792-A47AEB29-8BA1-41B4-BE42-0259AB8200FEQ37775960-C97158B6-6E10-48F7-A68A-F8CEDBD10872Q37855635-5D750253-FD51-496C-952A-9C485C9F0F90Q37951106-0D28F901-FE0C-4499-AC71-D8402E14B845Q37981271-E851E60E-B6C3-4F1B-B0F9-78AC942C4B2DQ38395937-2EC2CA61-7A3B-4752-AECC-B4744E642DD5Q38413932-0435A1D4-0A3C-4771-B03D-4B9BF128FE66Q38498051-77780717-108F-4385-8241-68791263FD38Q38582061-4FDCB442-FCE3-4D61-9941-1AA717826248Q38700777-2DC5DF43-A075-4993-A0E0-BFEC1B623E3FQ38734781-CACE222C-B582-4490-B704-1C41F0078424Q38811512-3B42088D-2919-4932-8021-2E99ADCE22F3Q38969098-7D08CA03-261D-4F4D-B592-094C74577305Q39586585-AF72FC4B-9695-441E-B9FC-77CB35A12408Q50725287-E966F7BD-C970-48B7-ABA8-51A523930B8BQ57820341-D1DB04C0-71AA-458E-B910-5AA427719C4D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use and safety of antipsychotic drugs during pregnancy.
@en
Use and safety of antipsychotic drugs during pregnancy.
@nl
type
label
Use and safety of antipsychotic drugs during pregnancy.
@en
Use and safety of antipsychotic drugs during pregnancy.
@nl
prefLabel
Use and safety of antipsychotic drugs during pregnancy.
@en
Use and safety of antipsychotic drugs during pregnancy.
@nl
P1476
Use and safety of antipsychotic drugs during pregnancy.
@en
P2093
Rada Boskovic
P304
P356
10.1097/01.PRA.0000351878.45260.94
P577
2009-05-01T00:00:00Z